Samantha Semenkow
Stock Analyst at Citigroup
(0.64)
# 3,880
Out of 4,876 analysts
43
Total ratings
22.86%
Success rate
-22.99%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Samantha Semenkow
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRME Prime Medicine | Downgrades: Neutral | $10 → $1.5 | $2.39 | -37.24% | 3 | May 27, 2025 | |
| CABA Cabaletta Bio | Maintains: Buy | $17 → $13 | $1.65 | +690.27% | 3 | May 16, 2025 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $8 → $4 | $1.19 | +236.13% | 3 | May 15, 2025 | |
| ARGX argenx SE | Maintains: Buy | $796 → $803 | $558.99 | +43.65% | 6 | May 9, 2025 | |
| GPCR Structure Therapeutics | Initiates: Buy | $60 | $20.97 | +186.12% | 1 | May 2, 2025 | |
| BIOA BioAge Labs | Maintains: Neutral | $7 → $5 | $4.21 | +18.76% | 3 | Mar 24, 2025 | |
| VYGR Voyager Therapeutics | Initiates: Buy | $12 | $2.88 | +317.39% | 1 | Dec 2, 2024 | |
| CPRX Catalyst Pharmaceuticals | Maintains: Buy | $27 → $31 | $21.77 | +42.40% | 2 | Aug 9, 2024 | |
| SANA Sana Biotechnology | Maintains: Buy | $8 → $15 | $2.83 | +430.97% | 2 | Aug 9, 2024 | |
| SNSE Sensei Biotherapeutics | Reinstates: Buy | $80 | $8.52 | +838.96% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $3.02 | +363.58% | 6 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $15 | $2.20 | +581.82% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $72 | $47.44 | +51.77% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $50 | $15.98 | +212.99% | 3 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $16.90 | +231.46% | 3 | Aug 9, 2023 |
Prime Medicine
May 27, 2025
Downgrades: Neutral
Price Target: $10 → $1.5
Current: $2.39
Upside: -37.24%
Cabaletta Bio
May 16, 2025
Maintains: Buy
Price Target: $17 → $13
Current: $1.65
Upside: +690.27%
Allogene Therapeutics
May 15, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.19
Upside: +236.13%
argenx SE
May 9, 2025
Maintains: Buy
Price Target: $796 → $803
Current: $558.99
Upside: +43.65%
Structure Therapeutics
May 2, 2025
Initiates: Buy
Price Target: $60
Current: $20.97
Upside: +186.12%
BioAge Labs
Mar 24, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $4.21
Upside: +18.76%
Voyager Therapeutics
Dec 2, 2024
Initiates: Buy
Price Target: $12
Current: $2.88
Upside: +317.39%
Catalyst Pharmaceuticals
Aug 9, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $21.77
Upside: +42.40%
Sana Biotechnology
Aug 9, 2024
Maintains: Buy
Price Target: $8 → $15
Current: $2.83
Upside: +430.97%
Sensei Biotherapeutics
Jun 3, 2024
Reinstates: Buy
Price Target: $80
Current: $8.52
Upside: +838.96%
May 22, 2024
Maintains: Buy
Price Target: $10 → $14
Current: $3.02
Upside: +363.58%
May 9, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $2.20
Upside: +581.82%
Dec 8, 2023
Initiates: Buy
Price Target: $72
Current: $47.44
Upside: +51.77%
Sep 27, 2023
Maintains: Buy
Price Target: $33 → $50
Current: $15.98
Upside: +212.99%
Aug 9, 2023
Maintains: Buy
Price Target: $60 → $56
Current: $16.90
Upside: +231.46%